Hospitalization for invasive pneumococcal disease in a national sample of children with sickle cell disease before and after PCV7 licensure
- PMID: 21793185
- PMCID: PMC4248562
- DOI: 10.1002/pbc.23259
Hospitalization for invasive pneumococcal disease in a national sample of children with sickle cell disease before and after PCV7 licensure
Abstract
Objective: To estimate national hospitalization rates for invasive pneumococcal disease (IPD) in children with sickle cell disease (SCD) before and after the 2000 licensure of the heptavalent pneumococcal conjugate vaccine (PCV7).
Procedure: We performed a retrospective trend analysis of the 1994-2007 Nationwide Inpatient Sample databases. Hospitalizations involving children with SCD and IPD were identified by ICD-9CM code. The primary outcomes, the annual hospitalization rate for IPD in children with SCD and the proportion of hospitalizations for IPD per 100 total SCD hospitalizations, were analyzed using multivariable linear regression and contingency analysis, respectively.
Results: A total of 1,242 hospitalizations for IPD in SCD patients were identified from 1994-2007, with a mortality rate of 2.4%. The national mean annual rate of IPD hospitalization decreased by 65%, from 131.8 cases/year from 1994 to 2000 to 45.5 cases/year from 2001 to 2007 (P = 0.001). The national proportion of hospitalizations for IPD per 100 total SCD hospitalizations decreased from 0.4 to 0.15 (P < 0.0001) over the same interval. Following PCV7 licensure, the mean annual cumulative hospital days and cumulative hospital charges decreased nationally by 53% and 36%, respectively.
Conclusion: In a national sample, PCV7 licensure is temporally associated with a nearly threefold reduction in IPD hospitalizations in children with SCD.
Copyright © 2011 Wiley Periodicals, Inc.
Figures
Similar articles
-
Invasive pneumococcal disease among children with and without sickle cell disease in the United States, 1998 to 2009.Pediatr Infect Dis J. 2013 Dec;32(12):1308-12. doi: 10.1097/INF.0b013e3182a11808. Pediatr Infect Dis J. 2013. PMID: 23811745 Free PMC article.
-
Incidence of invasive pneumococcal disease among individuals with sickle cell disease before and after the introduction of the pneumococcal conjugate vaccine.Clin Infect Dis. 2007 Jun 1;44(11):1428-33. doi: 10.1086/516781. Epub 2007 Apr 18. Clin Infect Dis. 2007. PMID: 17479937
-
Pneumococcal infections in children with sickle cell disease before and after pneumococcal conjugate vaccines.Blood Adv. 2023 Nov 14;7(21):6751-6761. doi: 10.1182/bloodadvances.2022009643. Blood Adv. 2023. PMID: 37698500 Free PMC article.
-
Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines.Clin Microbiol Rev. 2012 Jul;25(3):409-19. doi: 10.1128/CMR.00018-12. Clin Microbiol Rev. 2012. PMID: 22763632 Free PMC article. Review.
-
Burden of invasive pneumococcal disease and serotype distribution among Streptococcus pneumoniae isolates in young children in Europe: impact of the 7-valent pneumococcal conjugate vaccine and considerations for future conjugate vaccines.Int J Infect Dis. 2010 Mar;14(3):e197-209. doi: 10.1016/j.ijid.2009.05.010. Epub 2009 Aug 22. Int J Infect Dis. 2010. PMID: 19700359 Review.
Cited by
-
Safety and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, in children with SCD: a V114-023 (PNEU-SICKLE) study.Blood Adv. 2023 Feb 14;7(3):414-421. doi: 10.1182/bloodadvances.2022008037. Blood Adv. 2023. PMID: 36383730 Free PMC article. Clinical Trial.
-
Pneumococcal Immunization Strategies for High-Risk Pediatric Populations Worldwide: One Size Does Not Fit All.Vaccines (Basel). 2021 Nov 24;9(12):1390. doi: 10.3390/vaccines9121390. Vaccines (Basel). 2021. PMID: 34960136 Free PMC article. Review.
-
Small molecule therapeutics to treat the β-globinopathies.Curr Opin Hematol. 2020 May;27(3):129-140. doi: 10.1097/MOH.0000000000000579. Curr Opin Hematol. 2020. PMID: 32167945 Free PMC article. Review.
-
Incidence of invasive Haemophilus influenzae infections in children with sickle cell disease.Pediatr Blood Cancer. 2019 Jun;66(6):e27642. doi: 10.1002/pbc.27642. Epub 2019 Feb 5. Pediatr Blood Cancer. 2019. PMID: 30724001 Free PMC article.
-
Sickle Cell Anemia and Its Phenotypes.Annu Rev Genomics Hum Genet. 2018 Aug 31;19:113-147. doi: 10.1146/annurev-genom-083117-021320. Epub 2018 Apr 11. Annu Rev Genomics Hum Genet. 2018. PMID: 29641911 Free PMC article. Review.
References
-
- Barrett-Connor E. Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine (Baltimore) 1971;50(2):97–112. - PubMed
-
- Powars DR. Natural history of sickle cell disease--the first ten years. Semin Hematol. 1975;12(3):267–285. - PubMed
-
- Pearson HA, Spencer RP, Cornelius EA. Functional asplenia in sickle-cell anemia. N Engl J Med. 1969;281(17):923–926. - PubMed
-
- Overturf GD, Powars D, Baraff LJ. Bacterial meningitis and septicemia in sickle cell disease. Am J Dis Child. 1977;131(7):784–787. - PubMed
-
- Zarkowsky HS, Gallagher D, Gill FM, et al. Bacteremia in sickle hemoglobinopathies. J Pediatr. 1986;109(4):579–585. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
